Andrew Morton

Andrew Morton joined Ra Pharmaceuticals in 2016 and currently serves as Senior Director, Financial Planning & Analysis. At Ra Pharma, he led the design and implementation of various financial processes and systems with the goal of providing timely, accurate and insightful analytics for key decision makers throughout the organization. Prior to joining the Company, Andrew held a variety of Accounting and Finance positions of increasing responsibility at Tetraphase Pharmaceuticals. He received his B.S. in Business Administration from Northeastern University.